Risk factors for severe respiratory syncytial virus-associated respiratory tract infection in a high HIV prevalence setting, South Africa, 2012 - 2018.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
09 Oct 2024
Historique:
received: 23 05 2024
accepted: 01 10 2024
medline: 10 10 2024
pubmed: 10 10 2024
entrez: 9 10 2024
Statut: epublish

Résumé

Identifying risk factors for respiratory syncytial virus (RSV)-associated severe acute respiratory illness (SARI) will assist with targeting vaccine interventions. Using surveillance data from South Africa (2012-2018), we compared the characteristics of individuals with RSV-associated influenza-like illness (ILI) (reference group) to those with RSV-associated SARI to describe factors associated with SARI using a multivariable analysis. RSV was detected in 6% (483/7792) of ILI cases and 15% (844/5672) of SARI cases. Factors associated with SARI in children included age < 2 months, compared to age 2-4 years (adjusted odds ratio (aOR) 54.4; 95% confidence interval (CI) 23.5-125.8), malnutrition (aOR 1.9; 95% CI 1.2-3.2), prematurity (aOR 2.4; 95% CI 1.3-4.6) and living with HIV (LWH) (aOR 22.5; 95% CI 2.9-174.3). In individuals ≥ 5 years, factors associated with SARI included age ≥ 65 years compared to age 5-24 years (aOR 10.7; 95% CI 1.1-107.5), symptom duration ≥ 5 days (aOR 2.7; 95% CI 1.1-6.3), underlying illness (aOR 2.7; 95% CI 1.5-26.1) and LWH (aOR 16.8, 95% CI: 4.8-58.2). Individuals at the extremes of age and those with identified risk factors might benefit most from RSV prevention interventions. Not applicable, this is not a clinical trial.

Sections du résumé

BACKGROUND BACKGROUND
Identifying risk factors for respiratory syncytial virus (RSV)-associated severe acute respiratory illness (SARI) will assist with targeting vaccine interventions.
METHODS METHODS
Using surveillance data from South Africa (2012-2018), we compared the characteristics of individuals with RSV-associated influenza-like illness (ILI) (reference group) to those with RSV-associated SARI to describe factors associated with SARI using a multivariable analysis.
RESULTS RESULTS
RSV was detected in 6% (483/7792) of ILI cases and 15% (844/5672) of SARI cases. Factors associated with SARI in children included age < 2 months, compared to age 2-4 years (adjusted odds ratio (aOR) 54.4; 95% confidence interval (CI) 23.5-125.8), malnutrition (aOR 1.9; 95% CI 1.2-3.2), prematurity (aOR 2.4; 95% CI 1.3-4.6) and living with HIV (LWH) (aOR 22.5; 95% CI 2.9-174.3). In individuals ≥ 5 years, factors associated with SARI included age ≥ 65 years compared to age 5-24 years (aOR 10.7; 95% CI 1.1-107.5), symptom duration ≥ 5 days (aOR 2.7; 95% CI 1.1-6.3), underlying illness (aOR 2.7; 95% CI 1.5-26.1) and LWH (aOR 16.8, 95% CI: 4.8-58.2).
CONCLUSION CONCLUSIONS
Individuals at the extremes of age and those with identified risk factors might benefit most from RSV prevention interventions.
CLINICAL TRIAL NUMBER BACKGROUND
Not applicable, this is not a clinical trial.

Identifiants

pubmed: 39385077
doi: 10.1186/s12879-024-10024-9
pii: 10.1186/s12879-024-10024-9
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1128

Informations de copyright

© 2024. The Author(s).

Références

Shi T, McAllister DA, O’Brien KL, Simoes EAF, Madhi SA, Gessner BD, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet (London, England). 2017;390(10098):946–58.
doi: 10.1016/S0140-6736(17)30938-8 pubmed: 28689664 pmcid: 5592248
Moyes J, Tempia S, Walaza S, McMorrow ML, Treurnicht F, Wolter N, von Gottberg A, Kahn K, Cohen AL, Dawood H, Variava E, Cohen C. The burden of RSV-associated illness in children aged < 5 years, South Africa, 2011 to 2016. BMC Med. 2023;21(1):139. https://doi.org/10.1186/s12916-023-02853-3 . 
Nguyen-Van-Tam JS, O’Leary M, Martin ET, Heijnen E, Callendret B, Fleischhackl R, et al. Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries. Eur Respir Rev. 2022;31(166):220105.
doi: 10.1183/16000617.0105-2022 pubmed: 36384703 pmcid: 9724807
Moyes J, Walaza S, Pretorius M, Groome M, von Gottberg A, Wolter N, et al. Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting. J Infect. 2017;75(4):346–55.
doi: 10.1016/j.jinf.2017.06.007 pubmed: 28676408 pmcid: 5712433
McMorrow ML, Tempia S, Walaza S, Treurnicht FK, Moyes J, Cohen AL, Pretorius M, Hellferscee O, Wolter N, von Gottberg A, Nguweneza A, McAnerney JM, Naby F, Mekgoe O, Venter M, Madhi SA, Cohen C. The Role of Human Immunodeficiency Virus in Influenza- and Respiratory Syncytial Virus-associated Hospitalizations in South African Children, 2011-2016. Clin Infect Dis. 2019;68(5):773–80. https://doi.org/10.1093/cid/ciy532 .
Moyes J, Cohen C, Pretorius M, Groome M, von Gottberg A, Wolter N, et al. Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010–2011. J Infect Dis. 2013;208 Suppl 3(suppl 3):S217–226.
doi: 10.1093/infdis/jit479 pubmed: 24265481
Tempia S, Walaza S, Moyes J, Cohen AL, von Mollendorf C, Treurnicht FK, et al. Risk factors for influenza-associated severe acute respiratory illness hospitalization in South Africa, 2012–2015. Open Forum Infect Dis. 2017;4(1):1–10.
doi: 10.1093/ofid/ofw262
Cohen C, Moyes J, Tempia S, Groom M, Walaza S, Pretorius M, et al. Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009–2011. Emerg Infect Dis. 2013;19(11):1766–74.
doi: 10.3201/eid1911.130546 pubmed: 24209781 pmcid: 3837669
Organisation WH. RSV surveillance case defitions. 2014.
Fitzner J, Qasmieh S, Mounts AW, Alexander B, Besselaar T, Briand S, et al. Revision of clinical case definitions: influenza-like illness and severe acute respiratory infection. Bull World Health Organ. 2018;96(2):122–8.
doi: 10.2471/BLT.17.194514 pubmed: 29403115
Pretorius MA, Madhi SA, Cohen C, Naidoo D, Groome M, Moyes J, et al. Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness–South Africa, 2009–2010. J Infect Dis. 2012;206 Suppl 1(suppl_1):S159–165.
doi: 10.1093/infdis/jis538 pubmed: 23169964
Scheltema NM, Gentile A, Lucion F, James Nokes D, Munywoki PK, Madhi SA, et al. Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series. 2017.
Rudan I, O’Brien KL, Nair H, Liu L, Theodoratou E, Qazi S, et al. Epidemiology and etiology of childhood pneumonia in 2010: estimates of incidence, severe morbidity, mortality, underlying risk factors and causative pathogens for 192 countries. J Glob Health. 2013;3(1):010401–010401.
pubmed: 23826505 pmcid: 3700032
Scheltema NM, Gentile A, Lucion F, Nokes DJ, Munywoki PK, Madhi SA, et al. Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series. Lancet Glob Health. 2017;5(10):e984–91.
doi: 10.1016/S2214-109X(17)30344-3 pubmed: 28911764 pmcid: 5599304
Shi T, Balsells E, Wastnedge E, Singleton R, Rasmussen ZA, Zar HJ, et al. Risk factors for respiratory syncytial virus associated with acute lower respiratory infection in children under five years: systematic review and meta-analysis. J Glob Health. 2015;5(2):020416–020416.
doi: 10.7189/jogh.05.020416 pubmed: 26682048 pmcid: 4676580
Paynter S, Ware RS, Lucero MG, Tallo V, Nohynek H, Weinstein P, et al. Malnutrition: a risk factor for severe respiratory syncytial virus infection and hospitalization. Pediatr Infect Dis J. 2014;33(3):267–71.
doi: 10.1097/INF.0000000000000096 pubmed: 24168980
Ibrahim MK, Zambruni M, Melby CL, Melby PC. Impact of childhood malnutrition on host defense and infection. Clin Microbiol Rev. 2017;30(4):919–71.
doi: 10.1128/CMR.00119-16 pubmed: 28768707 pmcid: 5608884
Carbonell-Estrany X, Fullarton JR, Gooch KL, Gouyon J-B, Lanari M, Rodgers-Gray BS, et al. The influence of birth weight amongst 33–35 weeks gestational age (wGA) infants on the risk of respiratory syncytial virus (RSV) hospitalisation: a pooled analysis. J Matern Fetal Neonatal Med. 2017;30(2):134–40.
doi: 10.3109/14767058.2016.1165199 pubmed: 26965584
Health SADo. 2015-national-antenatal-hiv-prevalence-survey. 2015.
Rha B, Dahl RM, Moyes J, Binder AM, Tempia S, Walaza S, Bi D, Groome MJ, Variava E, Naby F, Kahn K, Treurnicht F, Cohen AL, Gerber SI, Madhi SA, Cohen C. Performance of Surveillance Case Definitions in Detecting Respiratory Syncytial Virus Infection Among Young Children Hospitalized With Severe Respiratory Illness-South Africa, 2009-2014. J Pediatric Infect Dis Soc. 2019;8(4):325–33. https://doi.org/10.1093/jpids/piy055 .
Voigt E, Tillmann RL, Schewe JC, Molitor E, Schildgen O. ARDS in an HIV-positive patient associated to respiratory syncytial virus. Eur J Med Res. 2008;13(3):131–2.
pubmed: 18499559
Gupta A, Mody P, Gupta S. A case of respiratory syncytial virus infection in an HIV-positive adult. Case Rep Infect Dis. 2012;2012:267028–267028.
pubmed: 23008789 pmcid: 3447325
Cunha BA, Syed U, Hage JE. Respiratory syncytial virus (RSV) community-acquired pneumonia (CAP) in a hospitalized adult with human immunodeficiency virus (HIV) mimicking influenza A and Pneumocystis (carinii) jiroveci pneumonia (PCP). Heart Lung. 2012;41(1):76–82.
doi: 10.1016/j.hrtlng.2011.05.004 pubmed: 22005289
Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis. 2004;189(2):233–8.
doi: 10.1086/380907 pubmed: 14722887
Falsey AR, McCann RM, Hall WJ, Tanner MA, Criddle MM, Formica MA, et al. Acute respiratory tract infection in daycare centers for older persons. J Am Geriatr Soc. 1995;43(1):30–6.
doi: 10.1111/j.1532-5415.1995.tb06238.x pubmed: 7806736 pmcid: 7166334
Falsey AR, Formica MA, Hennessey PA, Criddle MM, Sullender WM, Walsh EE. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;173(6):639–43.
doi: 10.1164/rccm.200510-1681OC pubmed: 16387798
Mehta J, Walsh EE, Mahadevia PJ, Falsey AR. Risk factors for respiratory syncytial virus illness among patients with chronic obstructive pulmonary disease. COPD. 2013;10(3):293–9.
doi: 10.3109/15412555.2012.744741 pubmed: 23536980
Brini I, Bhiri S, Ijaz M, Bouguila J, Nouri-Merchaoui S, Boughammoura L, Sboui H, Hannachi N, Boukadida J. Temporal and climate characteristics of respiratory syncytial virus bronchiolitis in neonates and children in Sousse, Tunisia, during a 13-year surveillance. Environ Sci Pollut Res Int. 2020;27(19):23379–89. https://doi.org/10.1007/s11356-018-3922-x .
Butler J, Gunnarsson R, Traves A, Marshall H. Severe respiratory syncytial virus infection in hospitalized children less than 3 years of age in a temperate and tropical climate. Pediatr Infect Dis J. 2019;38(1):6–11.
doi: 10.1097/INF.0000000000002026 pubmed: 30531526
Morley C, Grimwood K, Maloney S, Ware RS. Meteorological factors and respiratory syncytial virus seasonality in subtropical Australia. Epidemiol Infect. 2018;146(06):757–62.
doi: 10.1017/S0950268818000614 pubmed: 29560833
Sloan C, Heaton M, Kang S, Berrett C, Wu P, Gebretsadik T, et al. The impact of temperature and relative humidity on spatiotemporal patterns of infant bronchiolitis epidemics in the contiguous United States. Health Place. 2017;45:46–54.
doi: 10.1016/j.healthplace.2017.02.010 pubmed: 28285184 pmcid: 5502811
Nenna R, Evangelisti M, Frassanito A, Scagnolari C, Pierangeli A, Antonelli G, et al. Respiratory syncytial virus bronchiolitis, weather conditions and air pollution in an Italian urban area: n observational study. Environ Res. 2017;158:188–93.
doi: 10.1016/j.envres.2017.06.014 pubmed: 28647513 pmcid: 7125886
Chu HY, Katz J, Tielsch J, Khatry SK, Shrestha L, LeClerq SC, et al. Clinical presentation and birth outcomes associated with respiratory syncytial virus infection in pregnancy. PLoS ONE. 2016;11(3):e0152015–e0152015.
doi: 10.1371/journal.pone.0152015 pubmed: 27031702 pmcid: 4816499

Auteurs

Jocelyn Moyes (J)

Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, PVT Bag X4, Sandringham, Johannesburg, Gauteng, 2131, South Africa. jossmoyes@gmail.com.
School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. jossmoyes@gmail.com.

Stefano Tempia (S)

MassGenics, Duluth, GA, United States of America.
Centers for Disease Control and Prevention, Influenza Program, Pretoria, South Africa.

Sibongile Walaza (S)

Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, PVT Bag X4, Sandringham, Johannesburg, Gauteng, 2131, South Africa.
School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Adam L Cohen (AL)

Influenza Division, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Expanded Programme On Immunization Department of Immunization, Vaccines and Biologicals World Health Organization, Geneva, Switzerland.

Florette Treurnicht (F)

Division of Virology, Faculty of Health Sciences, National Health Laboratory Service, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.

Orienka Hellferscee (O)

Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, PVT Bag X4, Sandringham, Johannesburg, Gauteng, 2131, South Africa.

Nicole Wolter (N)

Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, PVT Bag X4, Sandringham, Johannesburg, Gauteng, 2131, South Africa.
School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Anne von Gottberg (A)

Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, PVT Bag X4, Sandringham, Johannesburg, Gauteng, 2131, South Africa.
School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Halima Dawood (H)

Department of Medicine, Greys Hospital, Pietermaritzburg, South Africa.
Caprisa, University of KwaZulu Natal, Pietermaritzburg, South Africa.

Ebrahim Variava (E)

Department of Medicine, Klerksdorp-Tshepong Hospital Complex, Klerksdorp, South Africa.
Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Kathleen Kahn (K)

School of Public Health, Faculty of Health Sciences, SAMRC/Wits Rural Public Health and Health Transitions Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Shabir A Madhi (SA)

South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand, Johannesburg, South Africa.

Cheryl Cohen (C)

Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, PVT Bag X4, Sandringham, Johannesburg, Gauteng, 2131, South Africa. cherylc@nicd.ac.za.
School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa. cherylc@nicd.ac.za.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH